OrbiMed Capital GP V LLC, Director, 10% Owner at Corvus Pharmaceuticals, Inc. (CRVS), bought 64,466 shares at $12.87 ($825K) on 2016-06-21, disclosed to the SEC on 2016-06-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.48 | 12,300 | $154K | 18.6% |
| 2 | $12.87 | 26,083 | $336K | 40.7% |
| 3 | $12.87 | 26,083 | $336K | 40.7% |
| Total | $12.80 avg | 64,466 | $825K | 100% |
| Filing → |
| CMPX | BUY | 2022-05-10 | $339K | — | Filing → |
| CRVS | SELL | 2021-09-22 | $13.5M | — | Filing → |
| ARPO | SELL | 2020-12-10 | $42K | — | Filing → |